JP2010503643A - キサントキシリンを主成分にした組成物および化粧品におけるその利用方法 - Google Patents

キサントキシリンを主成分にした組成物および化粧品におけるその利用方法 Download PDF

Info

Publication number: JP2010503643A
Authority: JP; Japan
Prior art keywords: xanthoxylin; extract; slimming; cosmetic composition; composition according
Prior art date: 2006-09-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2009527854A

Other languages

English (en)

Japanese (ja)

Inventor

シャルヴロン，マリ

ブローブル，フランソワーズ

ベル，ルネ

デュヌオ，クリストフ

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Dermo Cosmetique SA

Original Assignee

Pierre Fabre Dermo Cosmetique SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-15

Filing date

2007-09-11

Publication date

2010-02-04

2007-09-11 Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA

2010-02-04 Publication of JP2010503643A publication Critical patent/JP2010503643A/ja

Status Pending legal-status Critical Current

Links

FBUBVLUPUDBFME-UHFFFAOYSA-N Xanthoxylin Chemical compound COC1=CC(O)=C(C(C)=O)C(OC)=C1 FBUBVLUPUDBFME-UHFFFAOYSA-N 0.000 title claims abstract description 119
239000000203 mixture Substances 0.000 title claims abstract description 41
239000002537 cosmetic Substances 0.000 title claims abstract description 24
239000000419 plant extract Substances 0.000 claims abstract description 16
239000000284 extract Substances 0.000 claims description 49
238000000034 method Methods 0.000 claims description 21
241000196324 Embryophyta Species 0.000 claims description 12
239000006071 cream Substances 0.000 claims description 12
239000000499 gel Substances 0.000 claims description 11
241000221079 Euphorbia <genus> Species 0.000 claims description 10
239000004480 active ingredient Substances 0.000 claims description 10
230000000699 topical effect Effects 0.000 claims description 10
208000035484 Cellulite Diseases 0.000 claims description 9
206010049752 Peau d'orange Diseases 0.000 claims description 9
230000036232 cellulite Effects 0.000 claims description 9
241001448862 Croton Species 0.000 claims description 5
241000221017 Euphorbiaceae Species 0.000 claims description 5
244000089698 Zanthoxylum simulans Species 0.000 claims description 5
239000000546 pharmaceutical excipient Substances 0.000 claims description 5
239000007921 spray Substances 0.000 claims description 5
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 claims description 4
241001300740 Hippomane Species 0.000 claims description 4
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 4
230000035622 drinking Effects 0.000 claims description 4
239000000839 emulsion Substances 0.000 claims description 4
239000007903 gelatin capsule Substances 0.000 claims description 4
229940076640 hesperidin methylchalcone Drugs 0.000 claims description 4
239000006210 lotion Substances 0.000 claims description 4
239000002674 ointment Substances 0.000 claims description 4
239000000843 powder Substances 0.000 claims description 4
239000000725 suspension Substances 0.000 claims description 4
241000012923 Melicope borbonica Species 0.000 claims description 3
241001093501 Rutaceae Species 0.000 claims description 3
230000002265 prevention Effects 0.000 claims description 3
FDHNLHLOJLLXDH-JIYHLSBYSA-N (e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]prop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C(=O)C(C(=C1)OC)=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 FDHNLHLOJLLXDH-JIYHLSBYSA-N 0.000 claims description 2
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 claims description 2
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 2
240000003444 Paullinia cupana Species 0.000 claims description 2
235000000556 Paullinia cupana Nutrition 0.000 claims description 2
229940126902 Phlorizin Drugs 0.000 claims description 2
241000605385 Ruscus Species 0.000 claims description 2
229960001948 caffeine Drugs 0.000 claims description 2
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 2
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 claims description 2
IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 claims description 2
IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 claims description 2
235000019139 phlorizin Nutrition 0.000 claims description 2
150000003839 salts Chemical class 0.000 claims description 2
239000003826 tablet Substances 0.000 claims description 2
235000017060 Arachis glabrata Nutrition 0.000 claims 2
244000105624 Arachis hypogaea Species 0.000 claims 2
235000010777 Arachis hypogaea Nutrition 0.000 claims 2
235000018262 Arachis monticola Nutrition 0.000 claims 2
241000783088 Phebalium filifolium Species 0.000 claims 2
241000994241 Sapium Species 0.000 claims 2
241000949457 Zanthoxylum armatum Species 0.000 claims 2
244000131415 Zanthoxylum piperitum Species 0.000 claims 2
241000189398 Zanthoxylum rhoifolium Species 0.000 claims 2
235000020232 peanut Nutrition 0.000 claims 2
241000124033 Salix Species 0.000 claims 1
240000001949 Taraxacum officinale Species 0.000 claims 1
235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims 1
230000003796 beauty Effects 0.000 claims 1
235000020242 coleus extract Nutrition 0.000 claims 1
210000000689 upper leg Anatomy 0.000 description 38
238000005259 measurement Methods 0.000 description 23
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
230000000694 effects Effects 0.000 description 15
210000004027 cell Anatomy 0.000 description 13
210000001789 adipocyte Anatomy 0.000 description 12
230000004069 differentiation Effects 0.000 description 11
239000002904 solvent Substances 0.000 description 11
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
239000007788 liquid Substances 0.000 description 10
230000009467 reduction Effects 0.000 description 9
210000001519 tissue Anatomy 0.000 description 9
238000009825 accumulation Methods 0.000 description 8
150000003626 triacylglycerols Chemical class 0.000 description 8
235000013399 edible fruits Nutrition 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
239000000126 substance Substances 0.000 description 7
210000000577 adipose tissue Anatomy 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
238000011835 investigation Methods 0.000 description 6
239000000047 product Substances 0.000 description 6
241000269333 Caudata Species 0.000 description 5
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
230000008859 change Effects 0.000 description 5
238000000605 extraction Methods 0.000 description 5
239000000706 filtrate Substances 0.000 description 5
210000000229 preadipocyte Anatomy 0.000 description 5
235000011511 Diospyros Nutrition 0.000 description 4
244000236655 Diospyros kaki Species 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
239000003086 colorant Substances 0.000 description 3
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
229960003957 dexamethasone Drugs 0.000 description 3
239000003651 drinking water Substances 0.000 description 3
239000003205 fragrance Substances 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
239000002609 medium Substances 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
238000000746 purification Methods 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
235000003107 Artemisia maritima Nutrition 0.000 description 2
240000008118 Artemisia maritima Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
241000207199 Citrus Species 0.000 description 2
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
229920002125 Sokalan® Polymers 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
230000000843 anti-fungal effect Effects 0.000 description 2
230000000845 anti-microbial effect Effects 0.000 description 2
238000009835 boiling Methods 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
239000000490 cosmetic additive Substances 0.000 description 2
238000013480 data collection Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
102000057041 human TNF Human genes 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
238000000622 liquid--liquid extraction Methods 0.000 description 2
WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
230000008569 process Effects 0.000 description 2
238000004445 quantitative analysis Methods 0.000 description 2
238000010992 reflux Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
239000000523 sample Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
238000000638 solvent extraction Methods 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000003325 tomography Methods 0.000 description 2
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
238000002604 ultrasonography Methods 0.000 description 2
238000012800 visualization Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
239000001993 wax Substances 0.000 description 2
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
YCTSCXLOPJCPDH-UHFFFAOYSA-N 2-(3,7-dimethyl-2,6-dioxopurin-1-yl)acetic acid Chemical compound CN1C(=O)N(CC(O)=O)C(=O)C2=C1N=CN2C YCTSCXLOPJCPDH-UHFFFAOYSA-N 0.000 description 1
WGGPAKNHMZWYLL-UHFFFAOYSA-N 2-(hydroxymethoxy)-1-phenylethanone Chemical compound OCOCC(=O)C1=CC=CC=C1 WGGPAKNHMZWYLL-UHFFFAOYSA-N 0.000 description 1
235000003826 Artemisia Nutrition 0.000 description 1
235000003261 Artemisia vulgaris Nutrition 0.000 description 1
241000208838 Asteraceae Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
240000000572 Blumea balsamifera Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
235000005320 Coleus barbatus Nutrition 0.000 description 1
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
102000005927 Cysteine Proteases Human genes 0.000 description 1
108010005843 Cysteine Proteases Proteins 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
241001609099 Filifolium Species 0.000 description 1
241001300745 Hippomane mancinella Species 0.000 description 1
241001473010 Inuleae Species 0.000 description 1
241001299775 Melicope Species 0.000 description 1
NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
241001529733 Nepeta Species 0.000 description 1
241001123663 Penicillium expansum Species 0.000 description 1
241000783091 Phebalium tuberculosum Species 0.000 description 1
241000131459 Plectranthus barbatus Species 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
241000223238 Trichophyton Species 0.000 description 1
241000949456 Zanthoxylum Species 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000012675 alcoholic extract Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000001335 aliphatic alkanes Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
229940125681 anticonvulsant agent Drugs 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
244000030166 artemisia Species 0.000 description 1
235000009052 artemisia Nutrition 0.000 description 1
238000003556 assay Methods 0.000 description 1
210000001217 buttock Anatomy 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
235000020971 citrus fruits Nutrition 0.000 description 1
238000001816 cooling Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
229940067866 dandelion extract Drugs 0.000 description 1
235000020691 dandelion extract Nutrition 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
235000020188 drinking water Nutrition 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
230000005284 excitation Effects 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
244000053095 fungal pathogen Species 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
150000008282 halocarbons Chemical class 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
210000001624 hip Anatomy 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
229940011051 isopropyl acetate Drugs 0.000 description 1
GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
230000004130 lipolysis Effects 0.000 description 1
238000013507 mapping Methods 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
239000003921 oil Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000037361 pathway Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
238000011085 pressure filtration Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000011002 quantification Methods 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
239000005060 rubber Substances 0.000 description 1
-1 silica-like support Substances 0.000 description 1
230000008591 skin barrier function Effects 0.000 description 1
238000000859 sublimation Methods 0.000 description 1
230000008022 sublimation Effects 0.000 description 1
239000001845 taraxacum officinale leaf extract Substances 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229940042585 tocopherol acetate Drugs 0.000 description 1
210000003934 vacuole Anatomy 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
238000009834 vaporization Methods 0.000 description 1
230000008016 vaporization Effects 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Mycology (AREA)
Botany (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cosmetics (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

JP2009527854A 2006-09-15 2007-09-11 キサントキシリンを主成分にした組成物および化粧品におけるその利用方法 Pending JP2010503643A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0608129A FR2905854B1 (fr)	2006-09-15	2006-09-15	Composition a base de xanthoxyline et son utilisation en cosmetique
PCT/FR2007/001467 WO2008031940A2 (fr)	2006-09-15	2007-09-11	Composition a base de xanthoxyline et son utilisation en cosmetique.

Publications (1)

Publication Number	Publication Date
JP2010503643A true JP2010503643A (ja)	2010-02-04

Family

ID=37930368

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2009527854A Pending JP2010503643A (ja)	2006-09-15	2007-09-11	キサントキシリンを主成分にした組成物および化粧品におけるその利用方法

Country Status (16)

Country	Link
US (1)	US20100048729A1 (es)
EP (1)	EP2066408B1 (es)
JP (1)	JP2010503643A (es)
AR (1)	AR062855A1 (es)
AT (1)	ATE473784T1 (es)
BR (1)	BRPI0716754A8 (es)
CA (1)	CA2663387C (es)
DE (1)	DE602007007792D1 (es)
ES (1)	ES2345407T3 (es)
FR (1)	FR2905854B1 (es)
HR (1)	HRP20100485T1 (es)
MX (1)	MX2009002224A (es)
PL (1)	PL2066408T3 (es)
PT (1)	PT2066408E (es)
TW (1)	TWI382856B (es)
WO (1)	WO2008031940A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010180166A (ja) *	2009-02-06	2010-08-19	Pola Chem Ind Inc	痩身用の組成物
FR2986709B1 (fr) *	2012-02-09	2015-09-25	Nuxe Lab	Composition a base d'extrait d'ecorce de pommier utilisable en cosmetique
US20140120190A1 (en) *	2012-10-20	2014-05-01	Dong-Qing WEI	Methods of preparing prickly-ash peel extracts and cosmetic compositions incorporating prickly-ash peel extracts
WO2014092684A2 (en) *	2012-12-11	2014-06-19	Avon Products, Inc.	Use of melicope extracts to improve conditions caused by excess lipids
DE102013213596A1 (de)	2013-07-11	2015-01-15	Henkel Ag & Co. Kgaa	Mund- und Zahnpflege- und -reinigungsmittel zur Zahnfleischvitalisierung
FR3011180B1 (fr) *	2013-10-01	2017-01-06	Laboratoires De Biologie Vegetale Yves Rocher	Utilisation d'un extrait d'artemisia montana dans une composition cosmetique amincissante
FR3011179B1 (fr) *	2013-10-01	2017-01-06	Laboratoires De Biologie Vegetale Yves Rocher	Utilisation d'un extrait d'artemisia orientalis dans une composition cosmetique amincissante
US10603270B2 (en) *	2013-10-30	2020-03-31	Unigen, Inc.	Skin care compositions and methods of use thereof
CN110575413A (zh) *	2019-10-24	2019-12-17	山东花物堂生物科技有限公司	一种花椒提取物的制备方法及其在化妆品的应用
US20220401761A1 (en) *	2019-10-30	2022-12-22	Toyo Sugar Refining Co., Ltd.	Skin External Preparation for Cellulite Improvement and Cellulite Improvement Method
JP7736460B2 (ja) *	2021-06-28	2025-09-09	株式会社コーセー	メラニン産生抑制用組成物、ＢＭＰ４発現促進用組成物、ｃ－ＫＩＴ発現抑制用組成物、及び美白用化粧料

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6124511A (ja) *	1984-07-13	1986-02-03	Pola Chem Ind Inc	リツプ化粧料
JPH0881382A (ja) *	1994-09-13	1996-03-26	Kao Corp	脂肪分解促進剤
JP2000063237A (ja) *	1998-08-21	2000-02-29	Kanebo Ltd	脂肪分解促進剤及び痩身用皮膚化粧料
JP2003113104A (ja) *	2001-10-01	2003-04-18	Pola Chem Ind Inc	熱産生タンパク質発現促進剤及びそれを含有する組成物
JP2004051486A (ja) *	2002-07-16	2004-02-19	Pola Chem Ind Inc	熱産生交感神経活性化剤
JP2006096666A (ja) *	2002-10-31	2006-04-13	Kaneka Corp	選択的ヒトβ３アドレナリン受容体アゴニスト剤
JP2007186515A (ja) *	2003-05-02	2007-07-26	Takara Bio Inc	治療剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5523090A (en) *	1995-02-24	1996-06-04	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Skin treatment composition
IL122591A0 (en) *	1997-12-14	1998-06-15	Arad Dorit	Pharmaceutical compositions comprising cystein protease inhibitors
ITMI981542A1 (it) *	1998-07-07	2000-01-07	Indena Spa	Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
FR2807317B1 (fr) *	2000-04-10	2002-08-16	Indena Sa	Compositions de soin capillaire
JP2004035425A (ja) *	2002-07-01	2004-02-05	Naris Cosmetics Co Ltd	むくみ改善剤
ITMI20032286A1 (it) *	2003-11-24	2005-05-25	Indena Spa	Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
US20050271608A1 (en) *	2004-06-05	2005-12-08	Gupta Shyam K	Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives

2006
- 2006-09-15 FR FR0608129A patent/FR2905854B1/fr not_active Expired - Fee Related
2007
- 2007-09-11 BR BRPI0716754A patent/BRPI0716754A8/pt not_active Application Discontinuation
- 2007-09-11 US US12/310,960 patent/US20100048729A1/en not_active Abandoned
- 2007-09-11 WO PCT/FR2007/001467 patent/WO2008031940A2/fr not_active Ceased
- 2007-09-11 JP JP2009527854A patent/JP2010503643A/ja active Pending
- 2007-09-11 PL PL07823496T patent/PL2066408T3/pl unknown
- 2007-09-11 AT AT07823496T patent/ATE473784T1/de not_active IP Right Cessation
- 2007-09-11 DE DE602007007792T patent/DE602007007792D1/de active Active
- 2007-09-11 HR HR20100485T patent/HRP20100485T1/hr unknown
- 2007-09-11 CA CA2663387A patent/CA2663387C/fr active Active
- 2007-09-11 ES ES07823496T patent/ES2345407T3/es active Active
- 2007-09-11 EP EP07823496A patent/EP2066408B1/fr active Active
- 2007-09-11 MX MX2009002224A patent/MX2009002224A/es active IP Right Grant
- 2007-09-11 PT PT07823496T patent/PT2066408E/pt unknown
- 2007-09-14 AR ARP070104085A patent/AR062855A1/es unknown
- 2007-09-14 TW TW096134341A patent/TWI382856B/zh active

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6124511A (ja) *	1984-07-13	1986-02-03	Pola Chem Ind Inc	リツプ化粧料
JPH0881382A (ja) *	1994-09-13	1996-03-26	Kao Corp	脂肪分解促進剤
JP2000063237A (ja) *	1998-08-21	2000-02-29	Kanebo Ltd	脂肪分解促進剤及び痩身用皮膚化粧料
JP2003113104A (ja) *	2001-10-01	2003-04-18	Pola Chem Ind Inc	熱産生タンパク質発現促進剤及びそれを含有する組成物
JP2004051486A (ja) *	2002-07-16	2004-02-19	Pola Chem Ind Inc	熱産生交感神経活性化剤
JP2006096666A (ja) *	2002-10-31	2006-04-13	Kaneka Corp	選択的ヒトβ３アドレナリン受容体アゴニスト剤
JP2007186515A (ja) *	2003-05-02	2007-07-26	Takara Bio Inc	治療剤

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN6012062406; Ｊ．　Ｅｓｓｅｎｔ．　Ｏｉｌ　Ｒｅｓ．Ｖｏｌ．　１３, 2001, ｐｐ．１３６-１３９ *
JPN6014008862; 現代東洋医学Ｖｏｌ．１６，　Ｎｏ．３, 19950731, ｐ．７６-８２ *
JPN6014008865; Ｅｕｒ．　Ｊ．　Ｍｅｄ．　Ｃｈｅｍ．Ｖｏｌ．３１, 1996, ｐ．８３３-８３９ *
JPN6014008866; Ｐｌａｎｔａ　ＭｅｄｉｃａＶｏｌ．５６, 199002, ｐ．３１-３５ *
JPN6014008868; Ｐｌａｎｔａ　ＭｅｄｉｃａＶｏｌ．５６, 199004, ｐ．２４２，２４３ *

Also Published As

Publication number	Publication date
HRP20100485T1 (hr)	2010-10-31
FR2905854B1 (fr)	2010-07-30
PL2066408T3 (pl)	2010-12-31
ES2345407T3 (es)	2010-09-22
US20100048729A1 (en)	2010-02-25
WO2008031940A2 (fr)	2008-03-20
EP2066408B1 (fr)	2010-07-14
CA2663387C (fr)	2015-10-06
TW200835522A (en)	2008-09-01
EP2066408A2 (fr)	2009-06-10
CA2663387A1 (fr)	2008-03-20
MX2009002224A (es)	2009-04-30
AR062855A1 (es)	2008-12-10
DE602007007792D1 (de)	2010-08-26
PT2066408E (pt)	2010-09-29
TWI382856B (zh)	2013-01-21
ATE473784T1 (de)	2010-07-15
WO2008031940A3 (fr)	2008-05-22
BRPI0716754A2 (pt)	2013-09-17
BRPI0716754A8 (pt)	2017-09-12
FR2905854A1 (fr)	2008-03-21

Publication	Publication Date	Title
JP2010503643A (ja)	2010-02-04	キサントキシリンを主成分にした組成物および化粧品におけるその利用方法
TWI238724B (en)	2005-09-01	The pharmaceutical and cosmetic composition for increasing skin lipid with the component of vegetable oil
US12263239B2 (en)	2025-04-01	External composition containing ascorbic acid and/or salt thereof
AU2002304632B2 (en)	2006-07-20	Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
JP2019535783A (ja)	2019-12-12	トリュフ抽出物およびネオヘスペリジンジヒドロカルコンを含む組成物
JP2022511023A (ja)	2022-01-28	シスツス・モンスペリエンシス（Ｃｉｓｔｕｓｍｏｎｓｐｅｌｉｅｎｓｉｓ）の抽出物の新規な化粧品的及び皮膚科学的使用
JP2010520232A (ja)	2010-06-10	玄参抽出物を含有する外用剤組成物及びその皮膚保湿化粧料としての用途
JP2001288066A (ja)	2001-10-16	皮膚バリアー機能改善剤
JPH11322630A (ja)	1999-11-24	抗菌剤、並びにそれを含む皮膚外用剤及び皮膚洗浄剤
KR101322850B1 (ko)	2013-10-28	박하잎 추출물, 밀싹 추출물 및 길경 추출물을 유효성분으로 포함하는 모공 축소 또는 피지분비 억제용 화장료 조성물
JP6416433B1 (ja)	2018-10-31	皮膚外用剤
CN110179741A (zh)	2019-08-30	一种天然保湿的艾草护肤霜及其制备方法
JPWO1995019160A1 (ja)	1996-06-25	血流量改善剤及び化粧料
JP2010150237A (ja)	2010-07-08	セラミド産生促進剤、並びに該セラミド産生促進剤を用いた医薬品組成物、皮膚外用剤、化粧料組成物、及び化粧料
JP2001131047A (ja)	2001-05-15	アズキエキス含有化粧料組成物
JP3822517B2 (ja)	2006-09-20	皮膚外用剤
JP3536872B2 (ja)	2004-06-14	育毛剤
JP5746807B2 (ja)	2015-07-08	皮膚用化粧品の組成物
CN115209867B (zh)	2024-04-09	毛发生长促进用和/或白发改善用组合物
JP3755819B2 (ja)	2006-03-15	脂肪分解促進剤および痩身用皮膚化粧料
JP3543306B2 (ja)	2004-07-14	細胞賦活剤、及び抗酸化剤
JP3520936B2 (ja)	2004-04-19	育毛剤
JP5202180B2 (ja)	2013-06-05	保湿剤、免疫賦活剤、抗老化剤、美白剤、抗酸化剤、痩身剤、皮膚外用剤及び機能性経口組成物
CN121081324A (zh)	2025-12-09	具有医美术后修护作用的油脂组合物及其应用
JP4647733B2 (ja)	2011-03-09	経皮吸収促進外用剤

Legal Events

Date	Code	Title	Description
2010-07-27	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100726
2012-10-29	A977	Report on retrieval	Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20121029
2012-12-04	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121204
2013-02-28	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130227
2013-03-07	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130306
2013-04-04	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130403
2013-04-11	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130410
2013-05-03	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130502
2014-03-04	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140304
2014-06-04	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140603
2015-02-03	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150203